UPM Annual Report 2014
UPM Annual Report 2014
81
82
CONTENTS
ACCOUNTS
Year ended 31 December
EURm
Note
2014
2013
Sales
4
9,868
10,054
Other operating income
6
91
60
Costs and expenses
7
–8,708
–9,091
Change in fair value of biological assets and wood harvested
8
78
68
Share of results of associated companies and joint ventures
9
3
2
Depreciation, amortisation and impairment charges
10
–658
–545
Operating profit (loss)
4
674
548
Gains on available-for-sale investments, net
11
59
1
Exchange rate and fair value gains and losses
12
–4
10
Interest and other finance costs, net
12
–62
–84
Profit (loss) before tax
667
475
Income taxes
13
–155
–140
Profit (loss) for the period
512
335
Attributable to:
Owners of the parent company
512
335
Non-controlling interests
–
–
512
335
Earnings per share for profit (loss) attributable to owners of the parent company
Basic earnings per share, EUR
14
0.96
0.63
Diluted earnings per share, EUR
14
0.96
0.63
Consolidated financial statements, IFRS
Consolidated income statement
Consolidated statement of comprehensive income
Year ended 31 December
EURm
Note
2014
2013
Profit (loss) for the period
512
335
Other comprehensive income for the period, net of tax:
Items that will not be reclassified to income statement:
Actuarial gains and losses on defined benefit obligations
–181
69
Items that may be reclassified subsequently to income statement:
Translation differences
291
–219
Net investment hedge
–41
77
Cash flow hedges
–107
–28
Available-for-sale investments
–164
58
–21
–112
Other comprehensive income for the period, net of tax
13, 27
–202
–43
Total comprehensive income for the period
310
292
Total comprehensive income attributable to:
Owners of the parent company
310
292
Non-controlling interests
–
–
310
292
The income tax relating to each component of other comprehensive income is disclosed in Note 13.
Disclosure of components of other comprehensive income is presented in Note 27.
The notes are an integral part of these consolidated financial statements.
As at 31 December
EURm
Note
2014
2013
Assets
Non-current assets
Goodwill
16
230
219
Other intangible assets
17
340
342
Property, plant and equipment
18
4,707
4,757
Investment property
19
31
40
Biological assets
20
1,469
1,458
Investments in associated companies and joint ventures
21
25
22
Available-for-sale investments
22
2,510
2,661
Other non-current financial assets
23
334
282
Deferred tax assets
28
532
564
Other non-current assets
24
91
142
10,269
10,487
Current assets
Inventories
25
1,356
1,327
Trade and other receivables
26
1,856
1,948
Income tax receivables
14
50
Cash and cash equivalents
3
700
787
3,926
4,112
Total assets
14,195
14,599
As at 31 December
EURm
Note
2014
2013
Equity and liabilities
Equity attributable to owners of the parent company
Share capital
27
890
890
Treasury shares
–2
–2
Translation differences
256
6
Fair value and other reserves
27
1,867
2,256
Reserve for invested non-restricted equity
1,273
1,226
Retained earnings
3,194
3,073
7,478
7,449
Non-controlling interests
27
2
6
Total equity
7,480
7,455
Non-current liabilities
Deferred tax liabilities
28
428
501
Retirement benefit obligations
29
867
680
Provisions
30
214
189
Interest-bearing liabilities
31
3,058
3,485
Other liabilities
32
150
164
4,717
5,019
Current liabilities
Current interest-bearing liabilities
31
406
643
Trade and other payables
33
1,549
1,419
Income tax payables
43
63
1,998
2,125
Total liabilities
6,715
7,144
Total equity and liabilities
14,195
14,599
The notes are an integral part of these consolidated financial statements.
Consolidated balance sheet